Atossa Therapeutics
ATOS
#9237
Rank
C$0.14 B
Marketcap
C$1.10
Share price
5.24%
Change (1 day)
-34.37%
Change (1 year)

Atossa Therapeutics (ATOS) - Net assets

Net assets on the balance sheet as of June 2025 : C$79.7 Million

According to Atossa Therapeutics's latest financial reports the company has C$79.7 Million in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Atossa Therapeutics - Net assets on balance sheet (from 2010 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$C$0.10 B-15.04%
2023-12-31$C$0.12 B-24.58%
2022-12-31$C$0.16 B-9.07%
2021-12-31$C$0.17 B408.2%
2020-12-31$C$34.64 M101.61%
2019-12-31$C$17.18 M43.26%
2018-12-31$C$11.99 M37.49%
2017-12-31$C$8.72 M109.6%
2016-12-31$C$4.16 M-19.81%
2015-12-31$C$5.19 M-52.91%
2014-12-31$C$11.02 M-2.33%
2013-12-31$C$11.28 M119.28%
2012-12-31$C$5.14 M224.39%
2011-12-31$C$1.58 M-286.32%
2010-12-31$-C$0.86 Million

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Johnson & Johnson
JNJ
C$109.52 B 137,307.05%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
C$12.03 B 15,001.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
C$10.18 B 12,684.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
C$59.95 M-24.78%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
C$1.15 B 1,352.97%๐Ÿ‡บ๐Ÿ‡ธ USA